Diversion Quarterly — Q2 2020
Diversion Quarterly — Q2 2020
Kit Check is pulling data from its Bluesight™ for Controlled Substances platform on a quarterly…
Hospital Pharmacy Operations Report and Covid-19: Shortages and Diversion Risk are Top Concern
This week Kit Check released the results of our 2019 Hospital Pharmacy Operations Report (HPOR),…
Using AI to Prevent Diversion, Improve Efficiency, and Ensure Safety
A recent Pharmacy Technology Report article highlighted how Kit Check partner Children’s Hospital of the …
Diversion Quarterly — Q1 2020
Kit Check is pulling data from its Bluesight™ for Controlled Substances platform on a quarterly …
Bluesight for Controlled Substances Named Category Leader in Best in KLAS 2020 Report
Leading healthcare IT analyst firm KLAS today released its 2020 Best in KLAS report. We …
Kit Check’s Bluesight for Controlled Substances™ Named Category Leader for Drug Diversion Monitoring in 2020 Best in KLAS Report
KLAS report ranks Kit Check as the top performer with 93.9 rating for consistently delivering …
Kit Check’s Agreement with Vizient Extended in Multi-Year Contract, Providing Better Visibility in Drug Diversion and Medication Tracking
WASHINGTON (October 3, 2019) — Kit Check, the leader in automated medication management solutions for …
Kit Check’s Bluesight for Controlled Substances™ Recognized by KLAS as Leading Emerging Solution for Drug Diversion Monitoring
Bluesight for Controlled Substances heralded in industry report, earns rating of 93.2 out of 100 …
Bluesight for Controlled Substances Takes Top Score for Emerging Solutions in New KLAS Report
Leading healthcare IT analyst firm KLAS today published its inaugural drug diversion monitoring solution report. …
New Bluesight for Controlled Substances Feature: Investigation Portfolios
We are excited to announce the launch of our newest feature for the Bluesight for …